QA09

ICD-11 MMS 2026-01

Special screening examination for neoplasms

Exclusions from above levels

  • http://id.who.int/icd/entity/1144140024 – examinations related to pregnancy and reproduction
  • http://id.who.int/icd/entity/1617090159 – Clinical findings in blood, blood-forming organs, or the immune system

Child codes

  • QA09.0 – Special screening examination for neoplasm of stomach
  • QA09.1 – Special screening examination for neoplasm of intestinal tract
  • QA09.2 – Special screening examination for neoplasm of respiratory organs
  • QA09.3 – Special screening examination for neoplasm of breast
  • QA09.4 – Special screening examination for neoplasm of cervix
  • QA09.5 – Special screening examination for neoplasm of prostate
  • QA09.6 – Special screening examination for neoplasm of bladder
  • QA09.7 – Special screening examination for neoplasm of skin
  • QA09.Y – Other specified special screening examination for neoplasms
  • QA09.Z – Special screening for neoplasm of unspecified site

Sibling codes

  • QA00 – General examination or investigation of persons without complaint or reported diagnosis
  • QA01 – Examination or encounter for administrative purposes
  • QA02 – Medical observation or evaluation for suspected diseases or conditions, ruled out
  • QA03 – Routine general health check-up of defined subpopulation
  • QA04 – Examination or observation for reasons other than suspected diseases or conditions or administrative purposes
  • QA05 – Person consulting for explanation of investigation findings
  • QA06 – Follow-up examination after treatment for malignant neoplasms
  • QA07 – Follow-up examination after treatment for conditions other than malignant neoplasms
  • QA08 – Special screening examination for infectious diseases
  • QA0A – Special screening examination for other diseases or disorders
  • QA0B – Preprocedural examination
  • QA0Y – Other examination or investigation
  • QA0Z – Examination or investigation, unspecified

Foundation entity

Special screening examination for neoplasms – http://id.who.int/icd/entity/688906622

Allowed postcoordination axes

Part of: 24: Factors influencing health status or contact with health services